Form 8-K - Current report:
SEC Accession No. 0000950170-24-130440
Filing Date
2024-11-25
Accepted
2024-11-25 09:05:07
Documents
12
Period of Report
2024-11-22
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K drrx-20241122.htm   iXBRL 8-K 49258
2 EX-99.1 drrx-ex99_1.htm EX-99.1 23300
  Complete submission text file 0000950170-24-130440.txt   195636

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT drrx-20241122.xsd EX-101.SCH 29456
14 EXTRACTED XBRL INSTANCE DOCUMENT drrx-20241122_htm.xml XML 4509
Mailing Address 10240 BUBB ROAD CUPERTINO CA 95014
Business Address 10240 BUBB ROAD CUPERTINO CA 95014 4087771417
DURECT CORP (Filer) CIK: 0001082038 (see all company filings)

EIN.: 943297098 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-31615 | Film No.: 241492231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)